Short interest for Kimberly-Clark gives investors a sense of the degree to which investors are betting on the decline of Kimberly-Clark's stock. Short interest data is updated every two weeks.

Kimberly-Clark Stock (NYSE:KMB), Short Interest Report

Kimberly-Clark

With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Exxon Mobil

News

Short Ideas

Insider Trades

Pre-Market Outlook

Markets

SCHW

Exxon Mobil, Kimberly-Clark And 2 Other Stocks Insiders Are Selling

Market

Earnings

Equities

Previews

AAPL

ABBV

AMGN

AMZN

BBAI

BIIB

BJRI

BKNG

BLCO

CBOE

CHRW

CHTR

CMCSA

COIN

CYBR

DKNG

EBAY

ETSY

EXPE

FANG

FFIV

FIVN

FRSH

FSLR

GEHC

GILD

GRMN

ILMN

INTC

JBLU

JNPR

KLAC

KLIC

LOGI

LRCX

LSCC

With the earnings season now halfway through, the percentage of S&amp;P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week

GameStop35588099353_09b73955bf_k

Trading Ideas

GameStop, Kimberly-Clark And 2 Other Stocks Insiders Are Selling

Kimberly-Clark Corp

KAMBI GROUP LTD ORD B by Kambi Group LTD.

Kambi Group PLC

A substantial insider sell was reported on May 1, by Doug Cunningham, President at Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), based on the recent SEC filing.
What Happened: Cunningham's decision to sell 1,040 shares of Kimberly-Clark was revealed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000055785/000122520824005431//Archives/edgar/data/55785/000122520824005431/0001225208-24-005431-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday. The total value of the sale is $142,334.
In the Thursday's morning session, Kimberly-Clark's shares are currently trading at $136.25, experiencing a down of 0.16%.
<h3>Get to Know Kimberly-Clark Better</h3>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>Kimberly-Clark: Delving into Financials</h3>
Revenue Growth: Kimberly-Clark's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company experienced a revenue decline of approximately -0.89%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: With a low gross margin of 37.11%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): The company excels with an EPS that surpasses the industry average. With a current EPS of 1.92, Kimberly-Clark showcases strong earnings per share.
</li>
</ul>
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 7.63.
Exploring Valuation Metrics Landscape:
<ul>
<li>
Price to Earnings (P/E) Ratio: Kimberly-Clark's P/E ratio of 25.04 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 2.27 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Kimberly-Clark's EV/EBITDA ratio at 16.93 suggests potential undervaluation, falling below industry averages.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Exploring the Significance of Insider Trading</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Unlocking the Meaning of Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000055785">Check Out The Full List Of Kimberly-Clark's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Kimberly-Clark Insider Trades Send A Signal

The Nasdaq 100 closed lower by more than 300 points on Tuesday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Kimberly-Clark</h3>
<ul>
<li>The Trade: Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) Chief Bus. &amp; Transf. Officer Jeffrey P. Melucci <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 13,714 shares</a> at an average price of $135.53. The insider received around $1.86 million from selling those shares.</li>
<li>What's Happening: On April 23, Kimberly-Clark reported better-than-expected first-quarter financial results.</li>
<li>What Kimberly-Clark Does: With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm.</li>
</ul>
Have a look at our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a> 
<h3 class="wp-block-heading">Charles Schwab</h3>
<ul>
<li>The Trade: The Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) Co-Chairman Charles R. Schwab <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 119,811 shares</a> at an average price of $74.87. The insider received around $8.97 million from selling those shares.</li>
<li>What's Happening: On April 15, Charles Schwab reported better-than-expected first-quarter sales results.</li>
<li>What Charles Schwab Does: I Charles Schwab operates in brokerage, wealth management, banking, and asset-management businesses.</li>
</ul>
<h3 class="wp-block-heading">Exxon Mobil</h3>
<ul>
<li>The Trade: Exxon Mobil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) Vice President Darrin L Talley <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 2,426 shares</a> at an average price of $119.01. The insider received around $288,730 from selling those shares.</li>
<li>What's Happening: Exxon Mobil is reportedly in talks with Turkey for a multibillion-dollar deal for liquefied natural gas (LNG) as Ankara seeks to curb its dependence on Russia for energy needs.</li>
<li>What Exxon Mobil Does: ExxonMobil is an integrated oil and gas company that explores for, produces, and refines oil around the world.</li>
</ul>
<h3 class="wp-block-heading">United Rentals</h3>
<ul>
<li>The Trade: United Rentals, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) President &amp; CEO Matthew John Flannery <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 8,379 shares</a> at an average price of $699.63. The insider received around $5.86 million from selling those shares.</li>
<li>What's Happening: On April 24, United Rentals reported upbeat first-quarter financial results.</li>
<li>What United Rentals Does: United Rentals is the world&#8217;s largest equipment rental company.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/05/38542047/amazon-pfizer-and-3-stocks-to-watch-heading-into-wednesday">Amazon, Pfizer And 3 Stocks To Watch Heading Into Wednesday</a>

Corporate <a href="https://www.benzinga.com/markets/equities/24/04/38471231/strong-quarterly-earnings-fuel-market-optimism-despite-inflation-concerns-slowing-economic-growt">earnings came to the market&#8217;s rescue in the past week,</a> helping to overcome rate fears. As we look ahead to the unfolding week, it remains to be seen whether the tech earnings deluge can keep the rally&#8217;s momentum going. 
The Week That Was: High-profile Magnificent Seven earnings panned out mostly positively for the market, with Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) the outlier. The social media giant&#8217;s stock fell sharply as traders fretted over the soft second-quarter revenue guidance and the company&#8217;s massive AI investment plans. 
Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) managed to appease the Street despite the double miss as it held out the promise of an expeditious launch of a more affordable EV. 
With the earnings season now halfway through, the percentage of S&amp;P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages, <a href="https://insight.factset.com/sp-500-earnings-season-update-april-26-2024?utm_source=Direct&amp;utm_medium=Email&amp;utm_campaign=FO-04-26-2024&amp;utm_content=httpsinsightfactsetcomsp500earningsseasonupdateapril262024">said </a>FactSet in a report.
The blended first-quarter earnings growth of S&amp;P 500 companies is estimated at 3.5%, up from the 0.6% growth estimated in the week ended April 19, the financial data analytics firm said. If the trend holds, the S&amp;P 500 companies are on track to report earnings growth for the third straight quarter.
Of the 11 S&amp;P sector classes, eight sectors reported year-over-year earnings growth, led by communication services, utilities, IT, and consumer discretionary sectors. On the other hand, healthcare, energy, and materials have reported year-over-year earnings declines.
See Also: <a href="https://www.benzinga.com/money/best-tech-stocks">Best Tech Stocks Right Now</a>
Look Ahead: The unfolding week will see 175 S&amp;P 500 companies and 6 Dow 30 components releasing their quarterly scorecards. The earnings roster includes two Magnificent Seven companies, namely Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Amazon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), e-commerce retailers, payment processors, restaurants, and energy and REIT companies.
Earnings from Apple and Amazon could be market-moving, given the weighting of these stocks in the S&amp;P 500 Index. Also, Apple is considered a bellwether, given its exposure to consumers. Morgan Stanley&#8217;s Erik Woodring expects Apple to report a slightly beat but guide June quarter revenue down. 
Investors are likely to keep a close eye on performance in China, Apple&#8217;s updated capital return framework, and capital expenditures, the analyst said.
That said, the analyst is positive on the stock ahead of its annual Worldwide Developers&#8217; Conference due on June 10th. &#8220;With Apple&#8217;s biggest WWDC event on June 10th, we&#8217;d buy post-earnings weakness,&#8221; he said.
Amazon will likely continue to report double-digit sales and profit growth in the first quarter, according to Telsey Advisory Group analyst Joseph Feldman. The analyst premised his optimism on the strength of online spending, gains from expanded merchandise and faster fulfillment, and stabilization (and growth) of AWS. 
&#8220;Importantly, we expect [a] greater focus on profits supported by the growth of higher margin categories and services, such as advertising, media, and AWS (partly helped by AI-related upgrades), the redesigned distribution network&#8230;.. and cost savings,&#8221; he said.
Notable among the <a href="https://www.benzinga.com/calendars/earnings">companies reporting earnings this week</a> are:
Monday 
<ul>
<li>Before the bell: JinkoSolar Holding Co., Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JKS#NYSE">JKS</a>), ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>), Koninklijke Philips N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>), SoFi Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>)</li>
<li>After the close: F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>), Everest Group, Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EG#NYSE">EG</a>), NXP Semiconductors N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXPI#NASDAQ">NXPI</a>), Lattice Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>), MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>), Qiagen N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QGEN#NYSE">QGEN</a>), Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>), Sanmina Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANM#NASDAQ">SANM</a>), Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>)</li>
</ul>
Tuesday 
<ul>
<li>Before the bell: 3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), Archer-Daniels-Midland Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>), The Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>), McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>), Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>), PayPal Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>)</li>
<li>After the close: Advanced Micro Devices, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), ONEOK, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>), Pinterest, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>), Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), Skyworks Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>), Unum Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNM#NYSE">UNM</a>). Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), Stryker Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYK#NYSE">SYK</a>), RenaissanceRe Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>), Prudential Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>), Diamondback Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>), The Clorox Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>), Chesapeake Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHK#NASDAQ">CHK</a>)</li>
</ul>

Wednesday 
<ul>
<li>Before the bell: Bausch + Lomb Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>), CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), DuPont de Nemours, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>), The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>), Garmin Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GRMN#NYSE">GRMN</a>), GSK plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>), The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>), KKR &amp; Co. Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), Logitech International S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGI#NASDAQ">LOGI</a>), Mastercard Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), Norwegian Cruise Line Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>), Pfizer, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>), Wingstop Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>), Yum! Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>)</li>
<li>After the close: Albemarle Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALB#NYSE">ALB</a>), The Allstate Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>), Beazer Homes USA, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BZH#NYSE">BZH</a>), C.H. Robinson Worldwide, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>), Devon Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>), eBay Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NASDAQ">EBAY</a>), Etsy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>), First Solar, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>), Freshworks Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>), Kulicke and Soffa Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLIC#NASDAQ">KLIC</a>), Marathon Oil Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRO#NYSE">MRO</a>), MetLife, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>), MGM Resorts International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGM#NYSE">MGM</a>), NETGEAR, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTGR#NASDAQ">NTGR</a>), Qorvo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRVO#NASDAQ">QRVO</a>), Sunnova Energy International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOVA#NYSE">NOVA</a>), Upwork Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>), Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>), Zillow Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZG#NASDAQ">ZG</a>)</li>
</ul>
Thursday 
<ul>
<li>Before the bell: ArcelorMittal S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MT#NYSE">MT</a>), ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), CyberArk Software Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>), Ferrari N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RACE#NYSE">RACE</a>), Intercontinental Exchange, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>), Kimco Realty Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KIM#NYSE">KIM</a>), Moderna, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>), PENN Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENN#NASDAQ">PENN</a>), Wayfair Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>), Zoetis Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>)</li>
<li>After the close: Amgen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), Apple, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), BigBear.ai Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>), BJ&#8217;s Restaurants, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJRI#NASDAQ">BJRI</a>), Booking Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>), Cloudflare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>), Coinbase Global, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), Consolidated Edison, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>), DraftKings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>), Five9, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>), Expedia Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>), Illumina, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>), Live Nation Entertainment, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>), United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>), Regency Centers Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REG#NASDAQ">REG</a>), Reinsurance Group of America, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGA#NYSE">RGA</a>), Pioneer Natural Resources Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PXD#NYSE">PXD</a>), Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>), Monster Beverage Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>)</li>
</ul>
Friday 
<ul>
<li>Before the bell: American Axle &amp; Manufacturing Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>), Cboe Global Markets, Inc. (CBOE: CBOE), Fluor Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>), The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>), Owens &amp; Minor, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OMI#NYSE">OMI</a>), XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>)</li>
</ul>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), an exchange-traded fund that tracks the performance of the broader S&amp;P 500 Index, ended Friday&#8217;s session up 0.95% at $508.26, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data. </a>The ETF has pulled back from its all-time high (intraday) of $524.61 hit on March 28. The Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), an ETF levered more to high-profile, non-financial tech stocks, rose 1.54% to $431.
Read Next: <a href="https://www.benzinga.com/news/earnings/earnings-misses/24/04/38464570/us-energy-stocks-fall-following-oil-giants-subdued-earnings-reports">US Energy Stocks Fall Following Oil Giants&#8217; Subdued Earnings Reports</a>

The Nasdaq 100 closed lower by over 90 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">GameStop</h3>
<ul>
<li>The Trade: GameStop Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) PFO and PAO Daniel William Moore <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 7,779 shares</a> at an average price of $10.20. The insider received around $79,362 from selling those shares.</li>
<li>What's Happening: On March 26, GameStop reported fourth-quarter net sales of $1.794 billion, down from $2.226 billion year-over-year.</li>
<li>What GameStop Does: GameStop Corp is a U.S. multichannel video game, consumer electronics, and services retailer.</li>
</ul>
Have a look at our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<h3 class="wp-block-heading">SMART Global Holdings</h3>
<ul>
<li>The Trade: SMART Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGH#NASDAQ">SGH</a>) President, LED Solutions Joseph Gates Clark <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 2,529 shares</a> at an average price of $17.94. The insider received around $45,359 from selling those shares.</li>
<li>What's Happening: On April 9, the company saw third-quarter earnings of 30 cents per share, plus or minus 15 cents, versus the 28 cent estimate.</li>
<li>What SMART Global Does: SMART Global Holdings Inc is a designer and manufacturer of electronic products focused on memory and computing technology areas.</li>
</ul>
<h3 class="wp-block-heading">Kimberly-Clark</h3>
<ul>
<li>The Trade: Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) President, Latin America Gonzalo Uribe <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 1,465 shares</a> at an average price of $136.91. The insider received around $200,574 from selling those shares.</li>
<li>What's Happening: On April 23, Kimberly-Clark reported better-than-expected first-quarter financial results.</li>
<li>What Kimberly-Clark Does: With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm.</li>
</ul>
<h3 class="wp-block-heading">Bentley Systems</h3>
<ul>
<li>The Trade: Bentley Systems, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSY#NASDAQ">BSY</a>) Director Keith A. Bentley <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 17,021 shares</a> at an average price of $55.00. The insider received around $936,155 from selling those shares.</li>
<li>What's Happening: Schneider Electric recently confirmed holding discussions for a potential acquisition of Bentley Systems.</li>
<li>What Bentley Systems Does: Bentley Systems is a software vendor that caters to engineers, architects, constructors, and geospatial professionals by enabling design, modeling, simulation and project, and data management of infrastructure assets.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38452338/microsoft-alphabet-and-3-stocks-to-watch-heading-into-friday">Microsoft, Alphabet And 3 Stocks To Watch Heading Into Friday</a>

Barclays analyst Lauren Lieberman maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Equal-Weight and raises the price target from $132 to $136.

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Kimberly-Clark, Raises Price Target to $136

Paula Ramos, Chief Strategy Officer at Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), reported a large exercise of company stock options on April 24, according to a new SEC filing.
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0000055785/000122520824005189//Archives/edgar/data/55785/000122520824005189/0001225208-24-005189-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that Ramos, Chief Strategy Officer at Kimberly-Clark, a company in the Consumer Staples sector, just exercised stock options worth 10,178 shares of KMB stock with an exercise price of $132.63.
The Thursday morning update indicates Kimberly-Clark shares down by 0.81%, currently priced at $136.66. At this value, Ramos's 10,178 shares are worth $41,017.
<h3>Unveiling the Story Behind Kimberly-Clark</h3>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>Breaking Down Kimberly-Clark's Financial Performance</h3>
Negative Revenue Trend: Examining Kimberly-Clark's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -0.89% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company issues a cost efficiency warning with a low gross margin of 37.11%, indicating potential difficulties in maintaining profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Kimberly-Clark's EPS is significantly higher than the industry average. The company demonstrates a robust bottom-line performance with a current EPS of 1.92.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 7.63, Kimberly-Clark adopts a prudent financial strategy, indicating a balanced approach to debt management.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 25.28, the stock indicates an attractive valuation, potentially presenting a buying opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 2.29 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a lower-than-industry-average EV/EBITDA ratio of 17.07, Kimberly-Clark presents a potential value opportunity, as investors are paying less for each unit of EBITDA.
</li>
</ul>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
While insider transactions should not be the sole basis for making investment decisions, they can play a significant role in an investor's decision-making process.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Exploring Key Transaction Codes</h3>
For <a href="https://www.benzinga.com/money/investing-tools">investors</a>, a primary focus lies on transactions occurring in the open market, as indicated in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000055785">Check Out The Full List Of Kimberly-Clark's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options Exercise Activity Initiated By Paula Ramos At Kimberly-Clark

Citigroup analyst Filippo Falorni maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Sell and raises the price target from $111 to $125.

Citigroup Maintains Sell on Kimberly-Clark, Raises Price Target to $125

B of A Securities analyst Anna Lizzul maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Underperform and raises the price target from $110 to $115.

B of A Securities Maintains Underperform on Kimberly-Clark, Raises Price Target to $115

RBC Capital analyst Nik Modi maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Sector Perform and raises the price target from $123 to $126.

RBC Capital Maintains Sector Perform on Kimberly-Clark, Raises Price Target to $126

HSBC analyst Alejandro Zamacona maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Hold and raises the price target from $146 to $150.

HSBC Maintains Hold on Kimberly-Clark, Raises Price Target to $150

UBS analyst Peter Grom maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Neutral and raises the price target from $135 to $138.

UBS Maintains Neutral on Kimberly-Clark, Raises Price Target to $138

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Underweight and raises the price target from $115 to $123.

JP Morgan Maintains Underweight on Kimberly-Clark, Raises Price Target to $123

Wells Fargo analyst Chris Carey maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Equal-Weight and raises the price target from $131 to $136.

Wells Fargo Maintains Equal-Weight on Kimberly-Clark, Raises Price Target to $136

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $137.7, a high estimate of $152.00, and a low estimate of $123.00. Observing a 4.49% increase, the current average has risen from the previous average price target of $131.78. 
<img src="https://www.benzinga.com/files/images/story/2024/1713967241_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Kimberly-Clark. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jason English</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$152.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$132.00</td>
<td>$124.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$132.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Korinne Wolfmeyer</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$152.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$123.00</td>
<td>-</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$131.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Javier Escalante</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$150.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Alejandro Zamacona</td>
<td>HSBC</td>
<td>Raises</td>
<td>Hold</td>
<td>$146.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Jason English</td>
<td>Goldman Sachs</td>
<td>Maintains</td>
<td>Buy</td>
<td>$135.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$124.00</td>
<td>$128.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kimberly-Clark. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Kimberly-Clark compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Kimberly-Clark's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Kimberly-Clark's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/KMB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Kimberly-Clark analyst ratings.</a>
<h2>Unveiling the Story Behind Kimberly-Clark</h2>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>Understanding the Numbers: Kimberly-Clark's Finances</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Kimberly-Clark's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 0.12%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Kimberly-Clark's net margin is impressive, surpassing industry averages. With a net margin of 10.24%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Kimberly-Clark's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 63.82%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.95%, the company showcases effective utilization of assets.
Debt Management: Kimberly-Clark's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 8.87.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 10 Analyst Recommendations For Kimberly-Clark

Goldman Sachs analyst Jason English maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Buy and raises the price target from $135 to $152.

Goldman Sachs Maintains Buy on Kimberly-Clark, Raises Price Target to $152

Stocks surged across the board on Tuesday, gaining momentum after Monday&#8217;s rebound as unexpectedly weak economic data bolstered hopes for a potential Federal Reserve rate cut <a href="https://www.benzinga.com/federal-reserve">by the end of the summer</a>.
What Happened: The S&amp;P Global&#8217;s Purchasing Managers&#8217; Index (PMI) for April indicated a significant deceleration in private sector growth—the slowest in four months—also highlighting reduced inflationary pressures <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38381361/us-private-sector-growth-unexpectedly-slows-in-april-marks-lowest-increase-in-4-mon">from wages and services.</a>
Market-implied probabilities for a rate cut by the Fed as early as September jumped to 72%, up from 67% on Monday, according to CME Group&#8217;s FedWatch Tool. 
Meanwhile, corporate earnings have generally exceeded expectations, with investors now eagerly anticipating results from Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) and Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), slated for release after market close.
By midday trading in New York, the S&amp;P 500 climbed 1.2%, setting the stage for its best performance in over a month. The Nasdaq 100 outperformed the broader market, up 1.5%, while the Dow Jones Industrial Average saw a more modest increase of 0.6%.
The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) outperformed its large-cap counterparts, jumping 1.7% and marking its most significant gain since late March.
The dollar declined by 0.4%, and Treasury yields slightly fell. In the commodities market, gold remained steady following its sharpest drop in years on Monday, while oil prices inched 1% higher. Bitcoin edged down slightly by 0.3% to $66,640.
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,002.50</td>
<td>1.7%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>17,463.15</td>
<td>1.5%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,068.20</td>
<td>1.1%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>38,468.74</td>
<td>0.6%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:37 p.m. EDT</figcaption></figure>
The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 1.2% to $505.50, the&nbsp;SPDR Dow Jones Industrial Average (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) rose 0.6% to $384.94 and the tech-heavy&nbsp;Invesco QQQ Trust&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rallied 1.5% to $425.11, according to&nbsp;<a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.&nbsp;
Sector-wise, the Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) outperformed, up 1.8%. The Materials Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>) was the major laggard, down 0.5%. 
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h3>
<ul>
<li>Spotify Technology S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) saw its shares surge 17% following a robust earnings beat, setting the stock on course for its best single-day performance since its 2018 IPO.</li>
<li>Other companies reacting to recent earnings were Globe Life Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GL#NYSE">GL</a>), up 13%, GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>),up 7.3%, Danaher Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), up 7.3%, General Motors Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), up 5%, Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>), up nearly 3%, PepsiCo. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NYSE">PEP</a>), down 2.2%, United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>), up 2%, Xerox Holdings Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XRX#NYSE">XRX</a>), down 11%, MSCI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>), down 14%, LKQ Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>), down 14%, Halliburton Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>), flat, and Lockheed Martin Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), up 0.5%, </li>
<li>Notable names reporting after the close other than Tesla Inc. and Visa, Inc. are Texas Instruments, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Steel Dynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>), Seagate Technology Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), Mattel, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>), Chubb Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>), Canadian National Railway Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) and Baker Hughes Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>).</li>
</ul>
Now Read: <a href="https://www.benzinga.com/markets/asia/24/04/38380008/us-mulls-sanctions-on-beijing-banks-for-alleged-role-in-putins-war-in-ukraine-china-cant-have-it-bot">US Mulls Sanctions On Beijing Banks For Alleged Role In Putin&#8217;s War In Ukraine: &#8216;China Can&#8217;t Have It Both Ways,&#8217; Blinken Says</a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Large Cap

Macro Notification

Market Summary

Broad U.S. Equity ETFs

Commodities

Econ #s

Intraday Update

Tech

ETFs

SPDR Dow Jones Industrial Average ETF Trust

MSCI

SPOT

STLD

TSLA

Stocks Rally On Weaker PMI Data, Tech Earnings Optimism, Dollar Falls: What's Driving Markets Tuesday?

Kimberly-Clark Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) shares are gaining in the&nbsp;<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">premarket session on Tuesday</a>.
The company reported first-quarter adjusted earnings per share of $2.01,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/n38375057/kimberly-clark-announces-first-quarter-2024-results-and-raises-2024-outlook" rel="noreferrer noopener">beating the analyst consensus of $1.63</a>.
Quarterly revenues of $5.149 billion topped the street view of $5.085 billion. Net sales were down 1%, with organic sales growth of 6% <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">versus the prior year.</a>
Gross margin was 37.1%, up 390 basis points versus the prior year, driven by organic net sales growth and gross productivity gains.
Price-led gains reflected necessary pricing actions to address higher local costs in hyperinflationary economies, mainly in&nbsp;Argentina.&nbsp;
Volume and mix were positive across&nbsp;North America, developing and emerging (D&amp;E), and developed markets (represented&nbsp;Australia,&nbsp;South Korea, and Western/Central Europe).
Adjusted operating profit increased by 14% despite an unfavorable impact of 12 percentage points from currency translation, primarily driven by hyperinflationary economies.
Year-to-date capital spending was&nbsp;$194 million&nbsp;compared to $201&nbsp;million last year.&nbsp;
The company returned&nbsp;$452 million&nbsp;to shareholders through dividends and repurchases of common stock.&nbsp;
Total debt was&nbsp;$8 billion&nbsp;as of&nbsp;March 31, 2024, consistent with&nbsp;December 31, 2023.
Outlook:&nbsp;Organic net sales&nbsp;is&nbsp;now&nbsp;expected&nbsp;to grow mid-single digits (<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">prior view: low-to mid-single-digit growth</a>).&nbsp;
The company now expects&nbsp;reported net sales&nbsp;to&nbsp;be negatively impacted&nbsp;by 400 basis points of currency translation and 120 basis points from divestitures (prior view: 300 basis points and 60 basis points, respectively).
Adjusted EPS&nbsp;is now expected&nbsp;to grow at a low-teens percentage rate on a constant-currency basis (prior view: high-single-digit growth).
Price Action: KMB shares are trading higher by 5.5% to $136.02 premarket at the last check Tuesday.
Photo via Wikimedia Commons

Guidance

Movers

General

Kimberly-Clark +5% After Q1 Results - Here's Why

WIIM

Kimberly-Clark shares are trading higher after the company reported better-than-expected Q1 financial results.

Kimberley-Clark Boosts FY24 Adj EPS Outlook To low-Teens Percentage Rate Growth From High-Single-Digit Growth

Kimberley- Clark Updates FY24 Organic Net Sales Growth Outlook To Mid-Single Digits From The Previous Low-To Mid-Single-Digit

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Before considering which stocks to buy if inflation continues, it&rsquo;s good to remember the relationship between&nbsp;inflation and interest rates. The latest reading on CPI and PPI shows that the declining inflation rate may be ramping back up. &nbsp;



The takeaway is that the Fed is less likely to lower interest rates, which puts pressure on equities. But while some stocks will struggle, others are built to shine during rising inflation. These are the companies that deliver the products and services that consumers need to have regardless of what&rsquo;s happening in the economy. &nbsp;



A common trait of these companies is that they are mature companies with a consistent track record of generating positive revenue and earnings. When these companies&rsquo; stock outperforms the market, the companies can pass along that growth to shareholders.



<h2>PepsiCo (PEP)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/pep-pepsico-1600-300x169.png" alt="Pepsi (PEP) Factory in Samara, Russia. Pepsi logo on a blue warehouse."><div>Source: FotograFFF / Shutterstock</div></div>Investors seem to have a lot of reasons to talk down PepsiCo&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/pep-stock-quote/">PEP</a>) stock. Until recently, the stock had been lagging behind the broader market due to concerns about declining volume. There was concern over weight-loss drugs eating into the company&rsquo;s earnings. &nbsp;



But inflation is a great equalizer. While it&rsquo;s true that Pepsi has missed on revenue in its last two quarters, earnings are still higher than estimates for the quarter and on a year-over-year basis. &nbsp;



That speaks to pricing power, which investors should be looking for right now. Consumers may be pulling back, but Pepsi products are still getting its share of the consumer wallet. And when you buy PEP stock, you&rsquo;re buying a dividend king with a dividend yield of 2.85% and an annual payout of $4 per share.



Many investors could put Coca-Cola (NYSE:<a href="https://investorplace.com/stock-quotes/ko-stock-quote/">KO</a>) instead of Pepsi. Both stocks are dividend kings that show no sign of putting their respective streaks in danger. However, PEP stock has outperformed KO stock over the last five years by about 43%. &nbsp;



<h2>Kenvue (KVUE)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/kenvue-kvue-stock-1600-300x169.jpg" alt="Kenvue (KVUE) logo displayed on smartphone with company website in background"><div>Source: shutterstock.com/T. Schneider</div></div>Kenvue (NYSE:<a href="https://investorplace.com/stock-quotes/kvue-stock-quote/">KVUE</a>) is the consumer products spin-off from Johnson &amp; Johnson (NYSE:<a href="https://investorplace.com/stock-quotes/jnj-stock-quote/">JNJ</a>). When looking at inflation-beating stocks, JNJ would be a solid choice, but Kenvue merits strong consideration.&nbsp;



The company inherited Johnson &amp; Johnson&rsquo;s popular consumer brands, including Tylenol, Listerine, and Band-Aid. Yes, Kenvue also has its parent company&rsquo;s baby powder. Still, it carries none of the settlement costs from the lawsuit settlement after Johnson &amp; Johnson <a href="https://finance.yahoo.com/news/j-js-consumer-unit-named-052043484.html" target="_blank">indemnified Kenvue</a> from any of the talc-related liabilities. &nbsp;



In its first three quarters of reporting as an independent company, Kenvue has posted solid but not spectacular results. However, with many investors having an appetite for <a href="https://investorplace.com/industries/technology/">tech stocks</a> as opposed to <a href="https://investorplace.com/industries/consumer-discretionary/">consumer discretionary stocks</a>, KVUE stock is down 11% in its first year since going public. &nbsp;



But stickier inflation allows the company to remind investors why it&rsquo;s a viable safe-haven stock. And it&rsquo;s association with Johnson &amp; Johnson also grafts the company <a href="https://investorplace.com/2024/04/3-dividend-kings-down-11-youll-regret-not-buying-on-the-dip/" target="_blank">onto the list of dividend kings</a>. And KVUE stock already has a yield of over 4%. &nbsp;



<h2>Kimberly-Clark (KMB)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/kmb-stock-1-300x169.jpg" alt="Kimberly Clark (KMB) sign, positioned outside the world headquarters&rsquo; main entrance."><div>Source: Trong Nguyen / Shutterstock.com</div></div>Kimberly-Clark (NYSE:<a href="https://investorplace.com/stock-quotes/kmb-stock-quote/">KMB</a>) is next up on this list of stocks to buy if inflation continues. And no surprise, the company is another dividend king. The streak is 53 years, counting for Kimberly-Clark, and the dividend has an attractive yield of 3.56%.



Like many consumer products companies, the company has had its ups and downs since 2020, and so has KMB stock. This isn&rsquo;t a high flyer by any means. The stock is up just over 9% in the last five years. But times of high inflation are a boon to defensive stocks. In the month ending April 24, 2024, KMB stock is up 9.2%, pushing the stock higher for the year. &nbsp;



Inflation is also suitable for income investors. Yes, the company is guilty of &ldquo;shrinkflation,<a href="https://investorplace.com/2024/01/3-consumer-stocks-resorting-to-shrinkflation-tactics-signal-to-sell/" target="_blank">&rdquo;</a> which has boosted its bottom line. As a consumer, you hate it. As an investor, you like what higher earnings means for the company&rsquo;s future dividend growth. &nbsp;&nbsp;



<h2>CMS Energy (CMS)&nbsp;</h2>



<a href="https://investorplace.com/wp-content/uploads/2022/09/shutterstock_1784814938-scaled-e1679427565167.jpg"><img width="300" height="145" src="https://investorplace.com/wp-content/uploads/2022/09/shutterstock_1784814938-scaled-e1679427565167-300x145.jpg" alt="A 3D illustration of hydrogen molecules."></a>Utilities are a good place to look for stocks to buy if inflation continues. And a quality stock to consider is CMS Energy (NYSE:<a href="https://investorplace.com/stock-quotes/cms-stock-quote/">CMS</a>) or Consumers Energy. The company operates primarily as a regulated electric and gas utility in Michigan. The company also has a renewable energy business that just announced a partnership with&nbsp;Walmart (NYSE:<a href="https://investorplace.com/stock-quotes/wmt-stock-quote/">WMT</a>). Consumers Energy will provide clean energy to power 44 Walmart locations in Michigan. &nbsp;



The company has come to light on the top line in the last four quarters compared with analyst expectations. However, it&rsquo;s made up for it on the bottom line where it has come in higher year-over-year in each quarter. In the company&rsquo;s first quarter of 2024, the earnings report raised its guidance for the coming year. &nbsp;



Strong earnings are one reason that CMS stock is a favorite of Warren Buffett. The Oracle of Omaha owns company shares through his Berkshire-Hathaway (NSYE:<a href="https://investorplace.com/stock-quotes/brk.b-stock-quote/">BRK.B</a>) hedge fund. &nbsp;



<h2>Altria Group (MO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1926462137-300x169.png" alt="Altria Group, Inc. (MO) logo of US producer and marketer of tobacco and cigarettes is seen on a mobile phone screen."><div>Source: viewimage / Shutterstock.com</div></div>They may not be right for every portfolio, but sin stocks make great defensive stocks. Altria (NYSE:<a href="https://investorplace.com/stock-quotes/mo-stock-quote/">MO</a>) is one of the world&rsquo;s leading cigarette manufacturers, and the company has been increasingly moving into smokeless products (e.g., vapes). No matter your personal feelings about these products, there&rsquo;s no denying that Altria has a significant market share that will only grow. &nbsp;



However, a more compelling reason to buy MO stock while inflation is still firmly entrenched is the company&rsquo;s dividend, which currently has a 9% yield. Like many stocks on this list, Altria is a dividend king that has increased its dividend for 55 consecutive years. &nbsp;



After a rough 2023, investors may get the message on MO stock. The stock is up more than 7% as of April 25, 2024. And with the stock still down 5% in the last 12 months, there&rsquo;s plenty of stock price appreciation to go along with that dividend. &nbsp;



<h2>Albertson&rsquo;s (ACI)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/shutterstock_2146418893-300x169.jpg" alt="ACI stock: the Albertsons logo on the side of a building."><div>Source: Tada Images / Shutterstock</div></div>If you don&rsquo;t do the grocery shopping in your home, you may not appreciate what a savvy Albertson&rsquo;s (NYSE:<a href="https://investorplace.com/stock-quotes/aci-stock-quote/">ACI</a>) may be. With inflation exacting a stiff price on grocery bills, retail grocery chains have to give consumers a reason beyond price to visit their stores.&nbsp;



The company instituted a loyalty program that is showing strong YOY growth. It&rsquo;s also making advancements in its digital marketing program including online ordering with both home delivery and curbside pickup options. &nbsp;



These programs have allowed Albertson&rsquo;s to have a consistent top line. However, as is the case with many stocks on this list, the real story is robust bottom line growth. And while Albertson&rsquo;s is not a dividend king, it does pay a respectable dividend with a yield of 2.41%.



ACI stock is down 13% in 2024, some of which is because the regulators still decide if they&rsquo;ll allow the company&rsquo;s proposed merger with Kroger (NYSE:<a href="https://investorplace.com/stock-quotes/kr-stock-quote/">KR</a>). More will be known in August, but that would also be a catalyst for the stock. &nbsp;&nbsp;



<h2>Genuine Parts Company (GPC)&nbsp;</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/04/gpc1600-300x169.jpg" alt="Hands holding a smartphone with the Genuine Parts (GPC) logo displayed."><div>Source: Piotr Swat / Shutterstock.com</div></div>There are two solid cases for making Genuine Parts Company (NYSE:<a href="https://investorplace.com/stock-quotes/gpc-stock-quote/">GPC</a>) one of your stocks to buy if inflation continues. On its earnings call in April, the company acknowledged that it continues to be affected by inflation and higher interest rates. &nbsp;



But inflation cuts both ways. Many consumers are being priced out of newer vehicles. Or, in some cases, they find that dealers lack the models (i.e., traditional ICE vehicles) they may prefer. &nbsp;



This creates a situation where consumers try to keep their existing vehicles around for as long as possible. And the latest reading of the CPI showed that auto parts were one area where inflation was the stickiest. &nbsp;



The second reason is that Genuine Parts is yet another <a href="https://investorplace.com/2024/03/7-dividend-kings-that-offer-more-than-just-a-pretty-dividend/" target="_blank">dividend king</a> on this list. The company recently made it 69 consecutive years of increasing dividends. The yield of 2.51% is fairly average. However, the payout ratio of 44% easily supports future growth, particularly when analysts forecast high single-digit earnings growth in the next 12 months. &nbsp;



On the date of publication, Chris Markoch did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com <a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.&nbsp;




<div>Chris Markoch is a freelance financial copywriter who has been covering the market for over five years. He has been writing for InvestorPlace since 2019.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/7-stocks-to-buy-if-inflation-continues-to-be-a-problem-in-2024/">7 Stocks to Buy if Inflation Continues to Reign in 2024 </a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Stocks to Buy if Inflation Continues to Reign in 2024

16 High-Yield Dividend Aristocrats Yielding Almost 5%

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Investors rarely have a reason to ignore Dividend Aristocrat stocks. That&rsquo;s doubly true today with inflation remaining stubbornly high.&nbsp;



Over the last three months inflation has clocked in at 3.1%, 3.2%, <a href="https://www.statista.com/statistics/273418/unadjusted-monthly-inflation-rate-in-the-us/">and 3.5% most recently</a> in March. Fortunately, several of the dividend aristocrats include yields that effectively negate current inflation rates.&nbsp;



That&rsquo;s the point of this article. All of the Dividend Aristocrats are expected to outpace inflation through overall growth. However, those discussed below outpace or negate inflation through their dividends alone.&nbsp;



Combine that truth with their steady, strong nature and it&rsquo;s easy to see why investors often prefer the stock grouping. 25 plus consecutive years of dividend increases and growth throughout that period is a potent combination. Let&rsquo;s take a look at those companies and what they offer investors.



<h2>Dividend Aristocrat Stocks: Altria (MO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1926462137-300x169.png" alt="Altria Group, Inc. (MO) logo of US producer and marketer of tobacco and cigarettes is seen on a mobile phone screen."><div>Source: viewimage / Shutterstock.com</div></div>Altria (NYSE:<a href="https://investorplace.com/stock-quotes/mo-stock-quote/">MO</a>) is arguably the most at risk of the Dividend Aristocrat stocks discussed here. The reason is very simple: Altria includes a 9% dividend and operates within the waning&nbsp; tobacco industry.&nbsp;



Generally speaking, a 9% dividend is unsustainable and would normally be subject to cuts at any moment. Nevertheless, Altria looks very sustainable based on its dividend. Investors should expect the company to continue paying it for at least a few years.



Altria&rsquo;s payout ratio is 0.78. That means 78% of earnings dividend payments. It is a somewhat high but still manageable percentage. Recent moves suggest the company is in little danger. Altria <a href="https://www.barrons.com/articles/altria-sale-anheuser-busch-stock-a6586ecb">recently sold 18% of its stake</a> in Anheuser-Busch Inbev (NYSE:<a href="https://investorplace.com/stock-quotes/bud-stock-quote/">BUD</a>) allowing it to boost its repurchase plan.&nbsp;



Altria will increase its buyback plan from a total of $1 billion to $2.4 billion. That&rsquo;s important because it will allow the company to spend less on dividend payments as it retires more stock. In turn, that will lower the payout ratio to a degree making MO shares that much more attractive.&nbsp; The company will continue to grapple with the new tobacco landscape over the coming years. its success there will dictate its longer term trajectory. For the moment, the company is strong and includes a very high yield dividend.



<h2>Archer Daniels Midland (ADM)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/10/healthy-food-300x169.jpg" alt="BSFC Stock. Healthy food including salmon, almonds, garlic, broccoli, avocado, and lettuce"><div>Source: Shutterstock.com</div></div>Investors who&rsquo;ve been following Archer Daniels Midland (NYSE:<a href="https://investorplace.com/stock-quotes/adm-stock-quote/">ADM</a>) know that there is good news and bad news surrounding the company. That news has negatively affected its stock. It also sets up a rebound situation that&rsquo;s worth exploring.



That potential rebound situation is the good news for Archer Daniels Midland. The bad news is that the company continues to deal with the fallout from an investigation into accounting practices in its nutrition business. The good news is that its dividend does outpace inflation at 3.25% and that the repercussions of that investigation <a href="https://investorplace.com/2024/04/3-dividend-kings-down-11-youll-regret-not-buying-on-the-dip/">will likely be limited</a>.



The reason to believe so is that the company is cooperating with The SEC and the Justice Department. It has had to restate 6 years of profits from within its nutrition business. The company is essentially admitting a fault and has placed its CEO on leave. The likely outcome is penalties.



That sets up a situation in which ADM shares can rebound as the company moves past&nbsp; this current negative stage.&nbsp;



<h2>Dividend Aristocrat Stocks: Kimberly-Clark (KMB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/kmb-stock-1-300x169.jpg" alt="Kimberly Clark (KMB) sign, positioned outside the world headquarters&rsquo; main entrance."><div>Source: Trong Nguyen / Shutterstock.com</div></div>Kimberly-Clark (NYSE:<a href="https://investorplace.com/stock-quotes/kmb-stock-quote/">KMB</a>) is a solid, strongly performing company at the moment. That&rsquo;s probably the best reason to consider buying it right now. The fact that it also includes a dividend yielding 3.5% is arguably the icing on the cake.



<a href="https://investorplace.com/earning-results/2024/04/kmb-stock-earnings-kimberly-clark-for-q1-of-2024/">First quarter earnings and revenues</a> were better than expected from Kimberly-Clark. The $5.15 billion of revenues the company reported were 1.16% better than anticipated. Earnings of $2.01 were much better than the $1.63 Wall Street had been expecting.



The strong report has allowed the company to lift its annual forecast. It continues to see steady demand for its higher priced personal care products. It seems that inflation has done little to slow demand, at least as it relates to Kimberly-Clark.



Although inflation remains elevated, coming in at 3.5% in march, the company appears to be well insulated. KMB shares also include a 3.5% dividend which is another reason to consider buying.&nbsp;



<h2>Chevron (CVX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/03/cvx1600-300x169.jpg" alt="Chevron logo on blue sign in front of skyscraper building"><div>Source: Jeff Whyte / Shutterstock.com</div></div>Chevron (NYSE:<a href="https://investorplace.com/stock-quotes/cvx-stock-quote/">CVX</a>) stock is very interestingly positioned at the moment due to multiple factors.



Inflation remains elevated. Generally speaking, that&rsquo;s a net negative for oil producers. The higher inflation rises the more likely an economic slowdown becomes. In turn, that slowing economy consumes less oil, driving demand and prices lower.



However, there&rsquo;s an ongoing conflict in the Middle East that balances out the current threat of&nbsp; persistent inflation as it relates to oil prices. That continues to make Chevron stock highly intriguing. The inflation slows the economy thus the oil demand argument doesn&rsquo;t exactly hold here. CVX shares also include a dividend yielding approximately 4%. That strengthens the argument for investing even as inflation remains above 3%.&nbsp;



2024 has already proven the strength of the energy sector. <a href="https://investorplace.com/industries/energy/oil/">Oil stocks</a> in particular have performed very well. They&rsquo;ve outpaced the S&amp;P 500 so far. The energy sector is one of the best to consider at this point. It, along with artificial intelligence (AI), are going to continue commanding headline space for the time being. Chevron is a strong choice for those reasons and more.&nbsp;



<h2>Dividend Aristocrat Stocks: AbbVie (ABBV)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/01/abbv1600-300x169.png" alt="Closeup of AbbVie (ABBV) building corporate office, an American biopharmaceutical company with its headquarters in Lake Bluff, Illinois, USA"><div>Source: Valeriya Zankovych / Shutterstock.com</div></div>AbbVie (NYSE:<a href="https://investorplace.com/stock-quotes/abbv-stock-quote/">ABBV</a>) stock is moving again toward a period of strength after a period of significant instability. That instability was primarily due to Humira coming off patent and repercussions related thereto.



AbbVie has managed to navigate that period well. It has emerged successful on the other side. Humira anchored the company&rsquo;s Immunology portfolio. The company has long prepared for its eventual decline. Successor drugs including Rinvoq and Skyrizi now appear prepared to fill the void. The company continues to <a href="https://www.fiercepharma.com/pharma/amid-humira-trough-abbvie-dials-rinvoq-and-skyrizi-sales-goals-combined-27b">increase its forecast</a> for their future revenue potential.



In my mind it points to brighter days ahead for the company. One particular concern surrounding AbbVie is that <a href="https://www.gurufocus.com/stock/ABBV/analysis/warning-signs">asset growth outpaced revenue growth</a> over the past five years. The company has been in acquisition mode in order to find new sources of revenue to replace Humira&rsquo;s decline. Now that things are improving, the company should improve in that regard. The company is more secure and has overcome the Humira hurdle which will allow it to focus on improving efficiency rather than finding new revenue sources. It&rsquo;s 3.7% dividend makes it an inflation beater to boot.



<h2>Stanley Black &amp; Decker (SWK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/swk1600-300x169.png" alt="Stanley Black and Decker (SWK) is a manufacturer of industrial tools and household hardware and provider of security products"><div>Source: ricochet64 / Shutterstock.com</div></div>Investors should buy Stanley Black &amp; Decker (NYSE:<a href="https://investorplace.com/stock-quotes/swk-stock-quote/">SWK</a>)&nbsp;stock at the moment because it will help them beat inflation. They should hold it because it has massive potential to appreciate in price.



The 3.6% dividend the company pays outpaces current inflation. That dividend payment is secure based on a free cash flow payout ratio of 56%. Investors should essentially feel secure despite the fact that the company did suffer an earnings loss in 2023.&nbsp;



Mortgages remain high which is stunting demand for the tools that the company sells. Share prices have basically declined by 50% since late 2022. However, there will be a rebound and Stanley Black &amp; Decker will continue to pay a dividend in the meantime. Its FCF payout ratio is a strong indicator of that notion.&nbsp;



Shares are essentially deeply discounted at present due to housing market issues. Absent a complete collapse, Stanley Black &amp; Decker will continue to represent a strong rebound play currently beating inflation through its dividend.



<h2>Coca-Cola (KO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/coke-stock-1-300x169.jpg" alt="The website for Coca-Cola Consolidated (COKE) displayed on a smartphone screen."><div>Source: IgorGolovniov / Shutterstock.com</div></div>Coca-Cola (NYSE:<a href="https://investorplace.com/stock-quotes/ko-stock-quote/">KO</a>) is well known to be a company that thrives throughout the various stages of market cyclicality. Even the most bearish investors agree, Coca-Cola stock is a strong choice in the worst of times.



Thus, investors who are currently worried about inflation reigniting economic concerns should consider KO shares. Those shares include a dividend yielding 3.2%, roughly negating the current effects of inflation.&nbsp;



The other truth is that Coca-Cola is primarily a set-it-and-forget-it type of investment. Over the last 15 years it has essentially tripled in price. It has also steadily improved over that time frame with the exception of the pandemic onset. Anyway, very few investors would have bought KO shares at the moment it fell off a cliff. Even so, those who did, are up today.



Coca-Cola is a well-known defensive stock. Investors who are worried are leaning defensive right now, making KO shares attractive for that reason. In short, there are multiple narratives favoring investment in KO outside of its ability to outpace inflation through its dividend.



On the date of publication, Alex Sirois did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"> Publishing Guidelines</a>.
<div>Alex Sirois is a freelance contributor to InvestorPlace whose personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks. Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/04/inflation-proof-fortunes-7-dividend-aristocrats-to-keep-your-wealth-growing/">Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Inflation-Proof Fortunes: 7 Dividend Aristocrats to Keep Your Wealth Growing

Kimberly-Clark declares $1.22 dividend

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
After six months of calm, market volatility is increasing. Concerns about inflation, the upcoming election and seasonal weakness pose a headwind for stocks. To prepare for a surge in volatility, it&rsquo;s advisable to trim your growth stock winners and add some crash-resistant stocks.



Savvy investors have many reasons to seek defensive exposure. Due to persistent inflation rates, investors are <a href="https://www.reuters.com/markets/us/investors-brace-5-treasury-yields-us-inflation-worries-mount-2024-04-26/">bracing for higher rates</a>, which could negatively impact risk assets like stocks. Moreover, with the U.S. elections beckoning in November, the campaign season could heighten volatility.



Another market risk is seasonal weakness in the upcoming months. The <a href="https://www.fidelity.com/viewpoints/active-investor/sell-in-may">sell in May and go away phenomenon</a> could have a huge impact this year. We could be due for some weakness after a robust five-month performance that began in November 2023.



The following crash-resistant stocks have a beta below 0.5, meaning they are half as volatile as the market. They represent stable businesses with forward earnings growth above 5% and returns on equity above 20%. With low betas and forward price-to-earnings below 20, these stocks could outperform.



<h2>Kimberly-Clark (KMB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/kmb-stock-1-300x169.jpg" alt="Kimberly Clark (KMB) sign, positioned outside the world headquarters&rsquo; main entrance."><div>Source: Trong Nguyen / Shutterstock.com</div></div>We need essential personal care products and consumer tissue products in any environment. That&rsquo;s why Kimberly-Clark (NYSE:<a href="https://investorplace.com/stock-quotes/kmb-stock-quote/">KMB</a>) is one of the crash-resistant stocks. Furthermore, it trades at a reasonable valuation of 19 times forward earnings.



Kimberly-Clark sells essential personal care products in over 175 countries. These products range from Huggies diapers for baby care to Kotex for feminine care. Indeed, the company&rsquo;s products are essential to a quarter of the world&rsquo;s population.



Amidst its efforts to optimize its cost structure, the parent company of Cottonelle delivered strong <a href="https://investor.kimberly-clark.com/2024-04-23-Kimberly-Clark-Announces-First-Quarter-2024-Results-and-Raises-2024-Outlook">Q1 2024 results</a>. Although net sales decreased 1% to $5.1 billion, organic sales grew 6%.



Profitability was a highlight, with gross margins improving 390 basis points to 37.1% due to productivity gains. Operating profit surged from $787 million in the prior year quarter to $853 million, driving a 20% year-over-year (YOY) growth in adjusted earnings per share to $2.01.



Management&rsquo;s outlook for 2024 calls for mid-single-digit growth in organic net sales. Also, they raised their adjusted EPS growth from a previous forecast of high-single-digit growth to a low teens rate. Consumer tissue and personal care products are essentials that guarantee earnings stability for Kimberly-Clark. And with productivity improvements boosting earnings, it&rsquo;s one of the best crash-resistant stocks to buy.



<h2>Progressive (PGR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/pgr1600-300x169.jpg" alt="A white car with the Progressive logo written across the doors in big blue letters"><div>Source: Shutterstock</div></div>This <a href="https://www.statista.com/statistics/186443/top-us-commercial-auto-insurance-writers-by-market-share/">leading U.S. auto insurer</a> is already up 30% year-to-date (YTD) as it continues to increase insurance premiums. From an investment standpoint, Progressive (NYSE:<a href="https://investorplace.com/stock-quotes/pgr-stock-quote/">PGR</a>) is one of the best crash-resistant stocks to buy.



First, it&rsquo;s less volatile than the market due to its beta of 0.35. This means that even in the event of a correction, it should outperform the market. Second, the fundamental outlook for the auto insurance industry is positive. The fact that auto insurance is mandatory for car owners helps. Plus, after higher costs hampered profits over the last two years, auto insurers are now increasing premiums.



Industry-wise, Progressive has been in great shape due to its innovation. For instance, its early adoption of telematics lowered premiums relative to peers while driving underwriting profitability. As a result, it has consistently grown its market share against peers.



Looking further out, the insurer is well-positioned for growth. In 2023, Progressive had a 15.3% market share in the U.S. auto insurance market. Morgan Stanley&rsquo;s analyst Bob Jian Huang <a href="https://www.investing.com/news/stock-market-news/progressive-corp-raised-as-morgan-stanley-sees-credible-path-to-18-market-share-432SI-3326922">expects it to grow its share</a> to over 18% by 2028 due to its strong competitive position, innovation and market shift opportunities. It is one of the ideal crash-resistant stocks to weather volatility in a choppy market.



<h2>General Mills (GIS)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/10/GIS1600-300x169.jpg" alt="General Mills Cereal, GIS stock"><div>Source: designs by Jack / Shutterstock.com</div></div>General Mills (NYSE:<a href="https://investorplace.com/stock-quotes/gis-stock-quote/">GIS</a>) dominates the breakfast table and is a leader in the $10 billion cereals market. Its portfolio of strong brands, such as Cheerios and Nature Valley, has positioned the company for continued category leadership and deep retailer relationships.



Besides cereal, one of the best crash-resistant stocks has a growing pet business. Its pet food business, Blue Buffalo, accounts for 12% of revenues. The segment sells wet pet food, pet treats and dry pet food. This business has been a solid driver of organic sales growth.



Additionally, General Mills has taken strategic steps to accelerate its pet business and access other global markets. On April 30, it <a href="https://www.generalmills.com/news/press-releases/general-mills-advances-accelerate-strategy-and-expands-pet-food-portfolio">announced the acquisition</a> of Edgard &amp; Cooper, one of Europe&rsquo;s fastest-growing pet food companies. The deal adds high-quality pet brands and distribution capabilities across 13 European markets.



The strength in cereal makes General Mills one of the best crash-resistant stocks. Furthermore, the pet business will drive revenue growth over the long term as it becomes a larger component of total revenues. At 16 times forward earnings, this consumer staple is a bargain. Lastly, its low beta of 0.12 minimizes volatility, ensuring downside protection.



On the date of publication, Charles Munyi did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines.</a>




<div>Charles Munyi has extensive writing experience in various industries, including personal finance, insurance, technology, wealth management and stock investing. He has written for a wide variety of financial websites including Benzinga, The Balance and Investopedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/05/turbulent-times-3-stocks-that-could-outperform-in-a-market-crash/">Turbulent Times: 3 Stocks That Could Outperform in a Market Crash</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Turbulent Times: 3 Stocks That Could Outperform in a Market Crash

In a report released today, Korinne Wolfmeyer from Piper Sandler assigned a Buy rating to Kimberly Clark (KMB – Research Report), with a price targ...

Piper Sandler Issues a Buy Rating on Kimberly Clark (KMB)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
On Wall Street, many income-focused investors prioritize long-term stability and reliability over short-term volatility. Enter the Dividend Aristocrat stocks. 



These companies boast a remarkable track record of increasing their dividends for at least 25 consecutive years. Weathering market storms and economic downturns, they consistently reward shareholders with a dependable stream of income.



But dividend aristocrat stocks offer more than just consistent payouts. They often represent well-established companies with strong fundamentals, healthy balance sheets and a clear path for future growth. Including these reliable dividend payers in your portfolio can provide a valuable source of passive income, while potentially offering long-term capital appreciation. 



Let&rsquo;s explore three dividend aristocrat stocks that stand out for their robust business models and solid fundamentals.



<h2>Johnson &amp; Johnson (JNJ)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/10/jnj1600b-300x169.jpg" alt="jnj healthcare stocks"><div>Source: Raihana Asral / Shutterstock.com</div></div>Topping our list of dividend aristocrat stocks to buy is the global healthcare behemoth Johnson &amp; Johnson (NYSE:<a href="https://investorplace.com/stock-quotes/jnj-stock-quote/">JNJ</a>). The company currently operates across two segments: Janssen, its pharmaceutical segment, and Johnson &amp; Johnson MedTech, its medical technology segment. But management has recently announced that the former segment will now be rebranded as Johnson &amp; Johnson Innovative Medicine.



The healthcare titan announced strong <a href="https://www.investor.jnj.com/files/doc_financials/2024/q1/16/1q24-press-release_final-with-attachments.pdf">financial results for the first quarter</a> in April. Total sales rose 2.3% year-to-date (YTD) to $21.4 billion, while adjusted net earnings climbed 3.8% to $6.58 billion. Adjusted earnings per share (EPS) surged 12.4% to $2.71 per share. Management also raised the midpoint of full-year 2024 adjusted operational sales guidance from 5.5% to 5.8%.



Recently, Johnson &amp; Johnson MedTech announced it is <a href="https://www.jnj.com/media-center/press-releases/johnson-johnson-medtech-working-with-nvidia-to-scale-ai-for-surgery">working with</a> Nvidia (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvda-stock-quote/">NVDA</a>) to enable AI-based model development. As a result, the company is hoping to achieve real-time AI deployment through JNJ MedTech&rsquo;s digital surgery ecosystem. Research suggests between <a href="https://www.gminsights.com/industry-analysis/healthcare-artificial-intelligence-market?utm_source=globenewswire.com&amp;utm_medium=referral&amp;utm_campaign=Paid_globenewswire">2023 and 2032</a>, the AI-based healthcare segment should grow at a compound&nbsp;annual growth rate (CAGR) of over 29%.



Despite losing around 4% YTD, JNJ shares seem reasonably priced at 14.2x forward earnings. In addition, the stock offers a compelling 3.28% dividend yield.&nbsp;Analysts have a <a href="https://edition.cnn.com/markets/stocks/jnj">12-month price target</a> of $170 for JNJ, suggesting potential upside of close to 14% from current levels.



<h2>Air Products and Chemicals (APD)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/apd_air_products1600-300x169.png" alt="Air Products (APD) logo on the Arts Quest building, Air Products is a sponsor of Air Products Town Square at Arts Quest in Bethlehem, PA"><div>Source: Andy Borysowski / Shutterstock.com</div></div>Industrial gas manufacturer Air Products and Chemicals (NYSE:<a href="https://investorplace.com/stock-quotes/apd-stock-quote/">APD</a>) is another top pick as a dividend aristocrat stock. APD develops and operates some of the world&rsquo;s largest industrial gas projects. Their core business focuses on supplying atmospheric industrial gases to various industries. Those includ oxygen, nitrogen, argon, hydrogen and carbon dioxide, 



In late April, Air Products and Chemicals delivered mixed second quarter 2024 earnings. Revenue totaled $2.93 billion, down 8% from the previous year and falling short of estimates of $3.047 billion. On the other hand, adjusted net income rose to $694 million, a 7.6% increase compared to the prior-year quarter. Adjusted EPS came in at $2.85, up 4% from the previous year, and surpassing estimates of $2.69.



Recently, Air Products received funding to <a href="https://www.airproducts.com/company/news-center/2024/04/0415-funding-build-2-lg-scale-h2-refueling-stations-reg-of-n-rhine-westphalia-nordrhein-westfalen">build two large-scale hydrogen refueling stations</a> (HRS)in the region of North-Rhine Westphalia in Germany. These stations will have the capability of fueling a range of vehicles including medium and heavy-duty classes. Germany <a href="https://hydrogen-central.com/germany-triple-number-hydrogen-fuel-stations/">has been installing</a> HRSs as it decarbonizes its vast transportation network. The trend is likely to continue in the country as well as the rest of the European Union (EU).



Meanwhile, the APD board increased the quarterly dividend to $1.77 per share in January. At present, the stock offers a dividend yield of 2.96%. Since the start of the year, APD has tumbled more than 10%, making the stock even more attractive for income-focused investors. Currently, the shares trade at 19.3x forward earnings. Wall Street still remains bullish, with a <a href="https://edition.cnn.com/markets/stocks/apd">median 12-month price target</a> of $263, implying a potential 8% upside.



<h2>Kimberly-Clark (KMB)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/kmb-stock-1-300x169.jpg" alt="Kimberly Clark (KMB) sign, positioned outside the world headquarters&rsquo; main entrance."><div>Source: Trong Nguyen / Shutterstock.com</div></div>The final dividend aristocrat pick is <a href="https://investorplace.com/2024/05/turbulent-times-3-stocks-that-could-outperform-in-a-market-crash/">personal care consumer giant</a> Kimberly-Clark (NYSE:<a href="https://investorplace.com/stock-quotes/kmb-stock-quote/">KMB</a>). Some of its brands readers will recognize include Huggies, Pull-Ups, Poise, Kleenex, Scott and Cottonelle.&nbsp;



Recently, Kimberly-Clark announced <a href="https://investor.kimberly-clark.com/image/KMB+1Q+2024+Earnings+Press+Release.pdf">first quarter earning</a> results. Sales dipped 1% YOY to $5.1 billion, impacted mainly by foreign currency translation and divestitures in Brazil in June 2023. But adjusted net income jumped by 14% YOY to $658 million fueled by gross profit gains. Meanwhile, diluted EPS also increased 14% to $1.91 despite a negative impact from the company&rsquo;s transformation initiative.



In mid-March, the company outlined the <a href="https://www.news.kimberly-clark.com/2024-03-27-Kimberly-Clark-Unveils-Next-Chapter-of-Strategic-Transformation-to-Unlock-Highest-Value-Growth-Opportunities">next phase of its strategic plan</a>. Management is looking to revamp the operating model and key commercial initiatives with the aim of accelerating brand and business growth. As a result, investors will need to evaluate the steps being taken by Kimberly-Clark&rsquo;s management. 



Meanwhile, the board raised its quarterly payout to $1.22 per share in January. The shares currently have a dividend yield of 3.58%. Despite the volatility on Wall Street, KMB stock has gained a solid 13% YTD and now trades at 19.2x forward earnings. As the Street placed a <a href="https://edition.cnn.com/markets/stocks/kmb">median 12-month price target</a> of $136, interested readers may consider waiting for a pullback before buying KMB shares.



On the date of publication, Tezcan Gecgil held both long and short positions in NVDA stock.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Tezcan Gecgil, PhD, began contributing to InvestorPlace in 2018. She brings over 20 years of experience in the U.S. and U.K. and has also completed all 3 levels of the Chartered Market Technician (CMT) examination. Publicly, she has contributed to <a href="https://www.investing.com/">investing.com</a> and the U.K. website of <a href="https://www.fool.com/">The Motley Fool.</a></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/05/steady-dividend-plays-3-aristocrat-stocks-to-own-now/">Steady Dividend Plays: 3 Aristocrat Stocks to Own Now</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Steady Dividend Plays: 3 Aristocrat Stocks to Own Now

Kimberly-Clark: Downgrade To Sell On Negative Underlying Volume Performance

Kimberly-Clark: Long-Term Dividend Play Enjoys Some Momentum

Kimberly-Clark: Momentum Is Likely To Be Sustained In The Near-Term

KVUE

NVDA

WTRG

Press Releases

Kimberly-Clark to Announce First Quarter 2024 Financial Results on April 23, 2024

Kimberly-Clark Announces First Quarter 2024 Results and Raises 2024 Outlook

Liv by Kotex® Wants Moms to Laugh - and Pee a Little - this Mother's Day

Help Fight Period Poverty with U by Kotex®, Thinx® and Walgreens

Kimberly-Clark Professional™ Announces Greenovation Awards for Sustainability Leadership and Waste Reduction

Dividends

Kimberly-Clark Declares Quarterly Dividend

Kimtech™ Polaris™ Nitrile Exam Glove Earns ACT Label from My Green Lab®

The Innovators at Huggies® Announce a Pioneering Innovation to Take on Diaper Rash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Kimberly-Clark Stock (NYSE:KMB), Short Interest Report

People Also Watch